Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Regulatory landscapes for biomarkers and diagnostic tests: Qualification, approval, and role in clinical practice.

Mattes WB, Goodsaid F.

Exp Biol Med (Maywood). 2018 Feb;243(3):256-261. doi: 10.1177/1535370217739629. Epub 2017 Nov 7. Review.

2.
3.

Circulating mitochondrial biomarkers for drug-induced liver injury.

Shi Q, Yang X, Mattes WB, Mendrick DL, Harrill AH, Beger RD.

Biomark Med. 2015;9(11):1215-23. doi: 10.2217/bmm.15.59. Epub 2015 Oct 28. Review.

4.

Translating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validation.

Wang W, Shi Q, Mattes WB, Mendrick DL, Yang X.

Biomark Med. 2015;9(11):1177-88. doi: 10.2217/bmm.15.86. Epub 2015 Oct 26. Review.

5.

Scientific conduct... and misconduct.

Genter MB, Brock WJ, Mattes WB.

Toxicol Sci. 2015 Mar;144(1):3-4. No abstract available.

PMID:
25901331
6.

Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.

Yang X, Salminen WF, Shi Q, Greenhaw J, Gill PS, Bhattacharyya S, Beger RD, Mendrick DL, Mattes WB, James LP.

Toxicol Appl Pharmacol. 2015 Apr 15;284(2):180-7. doi: 10.1016/j.taap.2015.02.013. Epub 2015 Feb 21.

7.

Regorafenib impairs mitochondrial functions, activates AMP-activated protein kinase, induces autophagy, and causes rat hepatocyte necrosis.

Weng Z, Luo Y, Yang X, Greenhaw JJ, Li H, Xie L, Mattes WB, Shi Q.

Toxicology. 2015 Jan 2;327:10-21. doi: 10.1016/j.tox.2014.11.002. Epub 2014 Nov 6.

PMID:
25445804
8.

An integrated flow cytometry-based system for real-time, high sensitivity bacterial detection and identification.

Buzatu DA, Moskal TJ, Williams AJ, Cooper WM, Mattes WB, Wilkes JG.

PLoS One. 2014 Apr 9;9(4):e94254. doi: 10.1371/journal.pone.0094254. eCollection 2014.

9.

Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria.

Weng Z, Zhou P, Salminen WF, Yang X, Harrill AH, Cao Z, Mattes WB, Mendrick DL, Shi Q.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):1097-104. doi: 10.1016/j.bbrc.2013.12.110. Epub 2013 Dec 31.

PMID:
24384371
10.

Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling.

Mattes WB, Kamp HG, Fabian E, Herold M, Krennrich G, Looser R, Mellert W, Prokoudine A, Strauss V, van Ravenzwaay B, Walk T, Naraoka H, Omura K, Schuppe-Koistinen I, Nadanaciva S, Bush ED, Moeller N, Ruiz-Noppinger P, Piccoli SP.

Biomed Res Int. 2013;2013:202497. doi: 10.1155/2013/202497. Epub 2013 May 21.

11.

An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products.

Wang H, Mattes WB, Richter P, Mendrick DL.

Biomark Med. 2012 Dec;6(6):849-60. doi: 10.2217/bmm.12.78. Review.

PMID:
23227851
12.

Recommendations for biomarker identification and qualification in clinical proteomics.

Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, Ehrich JH, Fernandez-Llama P, Fliser D, Frokiaer J, Garin J, Girolami M, Hancock WS, Haubitz M, Hochstrasser D, Holman RR, Ioannidis JP, Jankowski J, Julian BA, Klein JB, Kolch W, Luider T, Massy Z, Mattes WB, Molina F, Monsarrat B, Novak J, Peter K, Rossing P, Sánchez-Carbayo M, Schanstra JP, Semmes OJ, Spasovski G, Theodorescu D, Thongboonkerd V, Vanholder R, Veenstra TD, Weissinger E, Yamamoto T, Vlahou A.

Sci Transl Med. 2010 Aug 25;2(46):46ps42. doi: 10.1126/scitranslmed.3001249.

PMID:
20739680
13.

Research at the interface of industry, academia and regulatory science.

Mattes WB, Walker EG, Abadie E, Sistare FD, Vonderscher J, Woodcock J, Woosley RL.

Nat Biotechnol. 2010 May;28(5):432-3. doi: 10.1038/nbt0510-432. No abstract available.

PMID:
20458309
14.

Translational toxicology and the work of the predictive safety testing consortium.

Mattes WB, Walker EG.

Clin Pharmacol Ther. 2009 Mar;85(3):327-30. doi: 10.1038/clpt.2008.270. Epub 2009 Jan 21. Review. No abstract available.

PMID:
19158666
15.

Public consortium efforts in toxicogenomics.

Mattes WB.

Methods Mol Biol. 2008;460:221-38. doi: 10.1007/978-1-60327-048-9_11.

PMID:
18449490
16.

Microarray probe mapping and annotation in cross-species comparative toxicogenomics.

Calley JN, Mattes WB, Ryan TP.

Methods Mol Biol. 2008;460:159-83. doi: 10.1007/978-1-60327-048-9_8.

PMID:
18449487
17.

Cross-species comparative toxicogenomics as an aid to safety assessment.

Mattes WB.

Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):859-74. Review.

PMID:
17125406
18.

Tissue and species distribution of the glutathione pathway transcriptome.

Mattes WB, Daniels KK, Summan M, Xu ZA, Mendrick DL.

Xenobiotica. 2006 Oct-Nov;36(10-11):1081-121.

PMID:
17118919
19.

Modulation of cell adhesion molecules in various epithelial cell lines after treatment with PP2.

Calcagno AM, Fostel JM, Orchekowski RP, Alston JT, Mattes WB, Siahaan TJ, Ware JA.

Mol Pharm. 2005 May-Jun;2(3):170-84.

PMID:
15934778
20.

Effects of an E-cadherin-derived peptide on the gene expression of Caco-2 cells.

Calcagno AM, Fostel JM, Reyner EL, Sinaga E, Alston JT, Mattes WB, Siahaan TJ, Ware JA.

Pharm Res. 2004 Nov;21(11):2085-94.

PMID:
15587932
21.

Gene expression analysis points to hemostasis in livers of rats cotreated with lipopolysaccharide and ranitidine.

Luyendyk JP, Mattes WB, Burgoon LD, Zacharewski TR, Maddox JF, Cosma GN, Ganey PE, Roth RA.

Toxicol Sci. 2004 Jul;80(1):203-13. Epub 2004 Apr 14.

PMID:
15084757
22.

Annotation and cross-indexing of array elements on multiple platforms.

Mattes WB.

Environ Health Perspect. 2004 Mar;112(4):506-10.

23.

Database development in toxicogenomics: issues and efforts.

Mattes WB, Pettit SD, Sansone SA, Bushel PR, Waters MD.

Environ Health Perspect. 2004 Mar;112(4):495-505. Review.

24.

Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.

Zimmer DM, Harbach PR, Mattes WB, Aaron CS.

Environ Mol Mutagen. 1999;33(3):249-56.

PMID:
10334627
25.

Spontaneous mutation spectrum at the lambda cII locus in liver, lung, and spleen tissue of Big Blue transgenic mice.

Harbach PR, Zimmer DM, Filipunas AL, Mattes WB, Aaron CS.

Environ Mol Mutagen. 1999;33(2):132-43.

PMID:
10217067
26.

Lack of response to multiple genotoxic agents at the hprt locus in peripheral blood T-lymphocytes of cynomolgus monkeys.

Zimmer DM, Harbach PR, Mattano SS, Yu RL, Mattes WB, Aaron CS.

Environ Mol Mutagen. 1999;33(2):123-31.

PMID:
10217066
27.

Effect of plating medium and phage storage on mutant frequency and titer in the lambda cII transgenic mutation assay.

Zimmer DM, Harbach PR, Mattes WB, Aaron CS.

Environ Mol Mutagen. 1998;32(4):325-30.

PMID:
9882006
28.

Contribution of serum protein association to discrepancy between the in vivo and in vitro UDS results for 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843).

Zhao Z, Koeplinger KA, Padbury GE, Aaron CS, Harbach PR, Mayo JK, Mattes WB, Bundy GL.

Mutat Res. 1997 Dec 12;395(2-3):119-26.

PMID:
9465922
29.
30.

Excision of DNA adducts of nitrogen mustards by bacterial and mammalian 3-methyladenine-DNA glycosylases.

Mattes WB, Lee CS, Laval J, O'Connor TR.

Carcinogenesis. 1996 Apr;17(4):643-8.

PMID:
8625472
31.

Correlation of frameshift mutagenicity with DNA intercalation by CGS 20928A using an in vitro DNA unwinding assay.

Mattes WB, Kapeghian JC, Lasinski ER, O'Lone SD, Puri EC, Matheson DW.

Environ Mol Mutagen. 1993;22(1):46-53.

PMID:
8339724
32.
34.

alpha-Naphthyl butyrate carboxylesterase activity in human and rat nasal tissue.

Mattes PM, Mattes WB.

Toxicol Appl Pharmacol. 1992 May;114(1):71-6.

PMID:
1585374
35.

Lesion selectivity in blockage of lambda exonuclease by DNA damage.

Mattes WB.

Nucleic Acids Res. 1990 Jul 11;18(13):3723-30.

36.

DNA damage and sequence specificity of DNA binding of the new anti-cancer agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis maleate)

Broggini M, Hartley JA, Mattes WB, Ponti M, Kohn KW, D'Incalci M.

Br J Cancer. 1990 Feb;61(2):285-9. Erratum in: Br J Cancer 1990 Jul;62(1):172.

37.

GC-rich regions in genomes as targets for DNA alkylation.

Mattes WB, Hartley JA, Kohn KW, Matheson DW.

Carcinogenesis. 1988 Nov;9(11):2065-72.

PMID:
2846198
38.

Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards.

Kohn KW, Hartley JA, Mattes WB.

Biochem Pharmacol. 1988 May 1;37(9):1799-800. No abstract available.

PMID:
3377838
39.

DNA sequence specificity of guanine N7-alkylations for a series of structurally related triazenes.

Hartley JA, Mattes WB, Vaughan K, Gibson NW.

Carcinogenesis. 1988 Apr;9(4):669-74.

PMID:
2833369
40.

DNA sequence specificity of antitumor agents. Oncogenes as possible targets for cancer therapy.

Hartley JA, Lown JW, Mattes WB, Kohn KW.

Acta Oncol. 1988;27(5):503-10. Review.

PMID:
2849464
41.

Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards.

Kohn KW, Hartley JA, Mattes WB.

Nucleic Acids Res. 1987 Dec 23;15(24):10531-49.

42.

The purification of the Escherichia coli UvrABC incision system.

Yeung AT, Mattes WB, Oh EY, Yoakum GH, Grossman L.

Nucleic Acids Res. 1986 Nov 11;14(21):8535-56.

43.

Mechanism of DNA strand breakage by piperidine at sites of N7-alkylguanines.

Mattes WB, Hartley JA, Kohn KW.

Biochim Biophys Acta. 1986 Oct 16;868(1):71-6.

PMID:
3756170
44.

DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards.

Mattes WB, Hartley JA, Kohn KW.

Nucleic Acids Res. 1986 Apr 11;14(7):2971-87.

45.

DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents.

Hartley JA, Gibson NW, Kohn KW, Mattes WB.

Cancer Res. 1986 Apr;46(4 Pt 2):1943-7.

46.
47.
48.

Enzymatic properties of purified Escherichia coli uvrABC proteins.

Yeung AT, Mattes WB, Oh EY, Grossman L.

Proc Natl Acad Sci U S A. 1983 Oct;80(20):6157-61.

49.

Amplification of the uvrA gene product of Escherichia coli to 7% of cellular protein by linkage to the pL promoter of pKC30.

Yoakum GH, Yeung AT, Mattes WB, Grossman L.

Proc Natl Acad Sci U S A. 1982 Mar;79(6):1766-70.

Supplemental Content

Loading ...
Support Center